Total and cause-specific mortality by elevated transferrin saturation and hemochromatosis genotype in individuals with diabetes - two general population studies

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Total and cause-specific mortality by elevated transferrin saturation and hemochromatosis genotype in individuals with diabetes - two general population studies. / Ellervik, Christina; Mandrup-Poulsen, Thomas; Tybjærg-Hansen, Anne; Nordestgaard, Børge G.

I: Diabetes Care, Bind 37, Nr. 2, 15.10.2013, s. 444-452.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Ellervik, C, Mandrup-Poulsen, T, Tybjærg-Hansen, A & Nordestgaard, BG 2013, 'Total and cause-specific mortality by elevated transferrin saturation and hemochromatosis genotype in individuals with diabetes - two general population studies', Diabetes Care, bind 37, nr. 2, s. 444-452. https://doi.org/10.2337/dc13-1198

APA

Ellervik, C., Mandrup-Poulsen, T., Tybjærg-Hansen, A., & Nordestgaard, B. G. (2013). Total and cause-specific mortality by elevated transferrin saturation and hemochromatosis genotype in individuals with diabetes - two general population studies. Diabetes Care, 37(2), 444-452. https://doi.org/10.2337/dc13-1198

Vancouver

Ellervik C, Mandrup-Poulsen T, Tybjærg-Hansen A, Nordestgaard BG. Total and cause-specific mortality by elevated transferrin saturation and hemochromatosis genotype in individuals with diabetes - two general population studies. Diabetes Care. 2013 okt. 15;37(2):444-452. https://doi.org/10.2337/dc13-1198

Author

Ellervik, Christina ; Mandrup-Poulsen, Thomas ; Tybjærg-Hansen, Anne ; Nordestgaard, Børge G. / Total and cause-specific mortality by elevated transferrin saturation and hemochromatosis genotype in individuals with diabetes - two general population studies. I: Diabetes Care. 2013 ; Bind 37, Nr. 2. s. 444-452.

Bibtex

@article{636cc4579ced4766a98202ec0fb91b8d,
title = "Total and cause-specific mortality by elevated transferrin saturation and hemochromatosis genotype in individuals with diabetes - two general population studies",
abstract = "ObjectiveMortality is increased in patients with hereditary hemochromatosis, in individuals from the general population with increased transferrin saturation(TS), and also in patients with diabetes type 1 and increased TS from a highly specialised diabetes clinic. Thus, we have recommended targeted screening for TS in specialised diabetes clinics. Whether mortality is also increased in individuals ascertained from the general population with diabetes and increased TS is unknown.Research design and methodsIn two Danish population studies(N=84,865), we examined mortality according to baseline TS and hemochromatosis genotype(HFE) C282Y/C282Y in individuals with diabetes(type 1,N=118;type 2,N=3228;total,N=3346).ResultsThe cumulative survival was reduced in individuals with diabetes with TS≥50% vs.",
author = "Christina Ellervik and Thomas Mandrup-Poulsen and Anne Tybj{\ae}rg-Hansen and Nordestgaard, {B{\o}rge G}",
year = "2013",
month = oct,
day = "15",
doi = "10.2337/dc13-1198",
language = "English",
volume = "37",
pages = "444--452",
journal = "Diabetes Care",
issn = "0149-5992",
publisher = "American Diabetes Association",
number = "2",

}

RIS

TY - JOUR

T1 - Total and cause-specific mortality by elevated transferrin saturation and hemochromatosis genotype in individuals with diabetes - two general population studies

AU - Ellervik, Christina

AU - Mandrup-Poulsen, Thomas

AU - Tybjærg-Hansen, Anne

AU - Nordestgaard, Børge G

PY - 2013/10/15

Y1 - 2013/10/15

N2 - ObjectiveMortality is increased in patients with hereditary hemochromatosis, in individuals from the general population with increased transferrin saturation(TS), and also in patients with diabetes type 1 and increased TS from a highly specialised diabetes clinic. Thus, we have recommended targeted screening for TS in specialised diabetes clinics. Whether mortality is also increased in individuals ascertained from the general population with diabetes and increased TS is unknown.Research design and methodsIn two Danish population studies(N=84,865), we examined mortality according to baseline TS and hemochromatosis genotype(HFE) C282Y/C282Y in individuals with diabetes(type 1,N=118;type 2,N=3228;total,N=3346).ResultsThe cumulative survival was reduced in individuals with diabetes with TS≥50% vs.

AB - ObjectiveMortality is increased in patients with hereditary hemochromatosis, in individuals from the general population with increased transferrin saturation(TS), and also in patients with diabetes type 1 and increased TS from a highly specialised diabetes clinic. Thus, we have recommended targeted screening for TS in specialised diabetes clinics. Whether mortality is also increased in individuals ascertained from the general population with diabetes and increased TS is unknown.Research design and methodsIn two Danish population studies(N=84,865), we examined mortality according to baseline TS and hemochromatosis genotype(HFE) C282Y/C282Y in individuals with diabetes(type 1,N=118;type 2,N=3228;total,N=3346).ResultsThe cumulative survival was reduced in individuals with diabetes with TS≥50% vs.

U2 - 10.2337/dc13-1198

DO - 10.2337/dc13-1198

M3 - Journal article

C2 - 24130348

VL - 37

SP - 444

EP - 452

JO - Diabetes Care

JF - Diabetes Care

SN - 0149-5992

IS - 2

ER -

ID: 96513135